REFERENCES
1. Greenberg JW, Lancaster TS, Schuessler RB, Melby SJ. Postoperative atrial fibrillation following cardiac surgery: a persistent complication. Eur J Cardiothorac Surg 2017;52:665-72.
2. Melby SJ, George JF, Picone DJ, et al. A time-related parametric risk factor analysis for postoperative atrial fibrillation after heart surgery. J Thorac Cardiovasc Surg 2015;149:886-92.
3. Maesen B, Nijs J, Maessen J, Allessie M, Schotten U. Post-operative atrial fibrillation: a maze of mechanisms. Europace 2012;14:159-74.
4. Dobrev D, Aguilar M, Heijman J, Guichard JB, Nattel S. Postoperative atrial fibrillation: mechanisms, manifestations and management. Nat Rev Cardiol 2019;16:417-36.
5. Mehaffey JH, Hawkins RB, Byler M, et al. Virginia Cardiac Services Quality Initiative. Cost of individual complications following coronary artery bypass grafting. J Thorac Cardiovasc Surg 2018;155:875-82.e1.
6. Echahidi N, Pibarot P, O’Hara G, Mathieu P. Mechanisms, prevention, and treatment of atrial fibrillation after cardiac surgery. J Am Coll Cardiol 2008;51:793-801.
7. Services CfMaM. Market Basket Data. Available from: https://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-and-Reports/MedicareProgramRatesStats/MarketBasketData.html [Last accessed on 29 Mar 2022].
8. Surgeons SoT. Adult Cardiac Surgery Data Collection. Available from: http://www.sts.org/sts-national-database/database-managers/adult-cardiac-surgery-database/data-collection#data2017 [Last accessed on 29 Mar 2022].
9. Shahian DM, O’Brien SM, Filardo G, et al. Society of Thoracic Surgeons Quality Measurement Task Force. The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 1--coronary artery bypass grafting surgery. Ann Thorac Surg 2009;88:S2-22.
10. Speir AM, Kasirajan V, Barnett SD, Fonner E Jr. Additive costs of postoperative complications for isolated coronary artery bypass grafting patients in Virginia. Ann Thorac Surg 2009;88:40-5; discussion 45-6.
11. Mehaffey JH, Hawkins RB, Byler M, et al. Amiodarone protocol provides cost-effective reduction in postoperative atrial fibrillation. Ann Thorac Surg 2018;105:1697-702.
12. LaPar DJ, Stukenborg GJ, Guyer RA, et al. Primary payer status is associated with mortality and resource utilization for coronary artery bypass grafting. Circulation 2012;126:S132-9.
13. Yount KW, Isbell JM, Lichtendahl C, et al. Bundled payments in cardiac surgery: is risk adjustment sufficient to make it feasible? Ann Thorac Surg 2015;100:1646-52; discussion 1652.
14. Hawkins RB, Mehaffey JH, Yount KW, et al. Investigators for the Virginia Cardiac Services Quality Initiative. Coronary artery bypass grafting bundled payment proposal will have significant financial impact on hospitals. J Thorac Cardiovasc Surg 2018;155:182-8.
15. LaPar DJ, Speir AM, Crosby IK, et al. Investigators for the Virginia Cardiac Surgery Quality Initiative. Postoperative atrial fibrillation significantly increases mortality, hospital readmission, and hospital costs. Ann Thorac Surg 2014;98:527-33; discussion 533.
16. Almassi GH, Wagner TH, Carr B, et al. VA #517 Randomized On/Off Bypass (ROOBY) Study Group. Postoperative atrial fibrillation impacts on costs and one-year clinical outcomes: the Veterans Affairs Randomized On/Off Bypass Trial. Ann Thorac Surg 2015;99:109-14.
17. Almassi GH, Pecsi SA, Collins JF, Shroyer AL, Zenati MA, Grover FL. Predictors and impact of postoperative atrial fibrillation on patients’ outcomes: a report from the Randomized On Versus Off Bypass trial. J Thorac Cardiovasc Surg 2012;143:93-102.
18. Almassi GH, Schowalter T, Nicolosi AC, et al. Atrial fibrillation after cardiac surgery: a major morbid event? Ann Surg 1997;226:501-11; discussion 511-3.
19. D’agostino RS, Jacobson J, Clarkson M, Svensson LG, Williamson C, Shahian DM. Readmission after cardiac operations: prevalence, patterns, and predisposing factors. J Thorac Cardiovasc Surg 1999;118:823-32.
20. Butler J, Harriss DR, Sinclair M, Westaby S. Amiodarone prophylaxis for tachycardias after coronary artery surgery: a randomised, double blind, placebo controlled trial. Br Heart J 1993;70:56-60.
21. Hoffmann MC. Evaluation of an evidence-based practice implementation: prophylactic amiodarone following coronary artery revascularization. Dimens Crit Care Nurs 2012;31:193-201.
22. Rostagno C. Recent developments in pharmacologic prophylaxis of atrial fibrillation in patients undergoing surgical revascularization. Cardiovasc Hematol Agents Med Chem 2009;7:137-46.
23. Chatterjee S, Sardar P, Mukherjee D, Lichstein E, Aikat S. Timing and route of amiodarone for prevention of postoperative atrial fibrillation after cardiac surgery: a network regression meta-analysis. Pacing Clin Electrophysiol 2013;36:1017-23.
